taurolidine has been researched along with Soft Tissue Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chromik, AM; Daigeler, A; Emmelmann, S; Haendschke, K; Hauser, J; Hensel, K; Klein-Hitpass, L; Lehnhardt, M; Schmitz, G; Siepmann, M; Steinau, HU | 1 |
| Braumann, C; Fuehrer, K; Hofmann, M; Jacobi, CA; Menenakos, C; Rogalla, S; Trefzer, U | 1 |
2 other study(ies) available for taurolidine and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma.
Topics: Analysis of Variance; Apoptosis; Contrast Media; Fibrosarcoma; Flow Cytometry; Gene Expression; Humans; Image Processing, Computer-Assisted; In Situ Nick-End Labeling; Oligonucleotide Array Sequence Analysis; Phospholipids; Soft Tissue Neoplasms; Sulfur Hexafluoride; Taurine; Thiadiazines; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Ultrasonic Therapy | 2010 |
The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model.
Topics: Animals; Antineoplastic Agents; Body Weight; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Injections, Intravenous; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Soft Tissue Neoplasms; Subcutaneous Tissue; Taurine; Thiadiazines | 2007 |